Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine

Simple item page
dc.contributor.authorCheung, Amy
dc.contributor.authorDewa, Carolyn
dc.contributor.authorMichalak, Erin E.
dc.contributor.authorBrowne, Gina
dc.contributor.authorLevitt, Anthony
dc.contributor.authorLevitan, Robert D.
dc.contributor.authorEnns, Murray W.
dc.contributor.authorMorehouse, Rachel L.
dc.contributor.authorLam, Raymond W.
dc.date.accessioned2015-05-14T16:24:44Z
dc.date.available2015-05-14T16:24:44Z
dc.date.issued2012-10-18
dc.date.updated2015-03-29T13:30:24Z
dc.description.abstractObjective. To compare the direct mental health care costs between individuals with Seasonal Affective Disorder randomized to either fluoxetine or light therapy. Methods. Data from the CANSAD study was used. CANSAD was an 8-week multicentre double-blind study that randomized participants to receive either light therapy plus placebo capsules or placebo light therapy plus fluoxetine. Participants were aged 18–65 who met criteria for major depressive episodes with a seasonal (winter) pattern. Mental health care service use was collected for each subject for 4 weeks prior to the start of treatment and for 4 weeks prior to the end of treatment. All direct mental health care services costs were analysed, including inpatient and outpatient services, investigations, and medications. Results. The difference in mental health costs was significantly higher after treatment for the light therapy group compared to the medication group—a difference of $111.25 (, ). However, when the amortized cost of the light box was taken into the account, the groups were switched with the fluoxetine group incurring greater direct care costs—a difference of $75.41 (, ). Conclusion. The results suggest that individuals treated with medication had significantly less mental health care cost after-treatment compared to those treated with light therapy.
dc.description.versionPeer Reviewed
dc.identifier.citationAmy Cheung, Carolyn Dewa, Erin E. Michalak, et al., “Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine,” Depression Research and Treatment, vol. 2012, Article ID 628434, 5 pages, 2012. doi:10.1155/2012/628434
dc.identifier.urihttp://dx.doi.org/10.1155/2012/628434
dc.identifier.urihttp://hdl.handle.net/1993/30488
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderCopyright © 2012 Amy Cheung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleDirect Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
DRT.2012.628434.xml
Size:
12.05 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
DRT.2012.628434.pdf
Size:
481.68 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.27 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works